Align Technology | Les Charges D'Exploitation



Operating Expenses Changement Date
3M USD 4.93B 283M 2024-12
Align Technology USD 851.07M 35.5M 2024-12
Becton, Dickinson and Co. USD 4.72B 74M 2024-12
Bruker USD 915.5M 119.2M 2024-12
Cardinal Health USD 54.72B 3.01B 2024-12
Charles River Laboratories USD 1.17B 277.88M 2024-12
Cooper Companies USD 782.7M 37.3M 2025-01
CVS Health USD 94.85B 255M 2024-12
Danaher USD 5.11B 273M 2024-12
Dentsply International USD 1.41B 1000K 2024-12
Dexcom USD 924.6M 82.4M 2024-12
Henry Schein USD 3.04B 19M 2024-12
Idexx Laboratories USD 692.6M 20.95M 2024-12
Insulet USD 488.2M 32.4M 2024-12
Integra LifeSciences USD 407.42M 18.45M 2024-12
IQVIA Holdings USD 3.33B 14M 2024-12
Masimo USD 959.8M 485.3M 2024-12
McKesson USD 94.07B 997M 2024-12
Mettler Toledo International USD 730.58M 884.93M 2024-12
Patterson Companies USD 1.53B 109.77M 2025-01
Revvity USD 610.62M 24.72M 2024-12
Solventum Corp 1.94B 131M 2024-12
Stryker USD 5.86B 1.45B 2024-12
Teleflex USD 905.79M 290.73M 2024-12
Thermo Fisher Scientific USD 9.38B 619M 2024-12
Veeva Systems USD 532.46M 14.61M 2025-01
Walgreens Boots Alliance USD 43.8B 4.12B 2025-02
Waters USD 580.45M 51.28M 2024-12
Zimmer Biomet Holdings USD 1.63B 89.5M 2024-12
Zoetis USD 1.59B 71M 2024-12



Align Technology Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.